Luyan Pharmaceutical (002788.SZ): Net profit of 83.7764 million yuan in the first quarter increased 4.90% year-on-year

Gelonghui, April 15, 丨 Luyan Pharmaceutical (002788.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 5.136 billion yuan, up 6.08% year on year; net profit attributable to shareholders of listed companies was 83.7764 million yuan, up 4.90% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 82.7597 million yuan, up 5.21% year on year; basic earnings per share were 0.22 yuan.

Gelonghui FinanceApr 15 05:04 ET

Earnings Working Against Luyan Pharma Co.,Ltd.'s (SZSE:002788) Share Price Following 29% Dive

The Luyan Pharma Co.,Ltd. (SZSE:002788) share price has fared very poorly over the last month, falling by a substantial 29%. The drop over the last 30 days has capped off a tough year for sharehold

Simply Wall StFeb 5 17:41 ET

Luyan Pharmaceutical (002788.SZ) received concerted action from controlling shareholder Wang Jun to increase holdings by 372,000 shares

Zhitong Finance App News, Luyan Pharmaceutical (002788.SZ) issued an announcement. On February 2, 2024, the company received a notice from Ms. Wang Jun, the controlling shareholder of Xiamen Medicon Technology Co., Ltd. (“Medican”). Based on confidence in the company's future continuous and stable development and reasonable judgment on the company's current investment value, Ms. Wang Jun increased her shareholding by 372,000 shares through the Shenzhen Stock Exchange stock trading system on February 2, 2024 through centralized bidding.

Zhitong FinanceFeb 5 05:49 ET

Luyan Pharmaceutical (002788.SZ) has not carried out research on the practical application of blockchain technology in the field of pharmaceutical product distribution

Gelonghui, Feb. 4 | Luyan Pharmaceutical (002788.SZ) said on the investor interactive platform that the company is concerned about the development and application of new technologies and continues to use them to enhance the company's business. However, research on the actual application of blockchain technology in the field of pharmaceutical product distribution has not yet been carried out.

Gelonghui FinanceFeb 4 02:13 ET

Here's What To Make Of Luyan PharmaLtd's (SZSE:002788) Decelerating Rates Of Return

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (ROCE) th

Simply Wall StFeb 2 19:23 ET

Four Luyan Pharmaceutical (002788.SZ) executives reduced their holdings in the company by a total of 0.25%

Luyan Pharmaceutical (002788.SZ) issued an announcement. As of the announcement date, Zhang Junying had not reduced the company's shares. Li Weiyang,...

Zhitong FinanceNov 8, 2023 06:19 ET